CVI INJECTORS
Total Payments
$300,563
Transactions
31
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $300,563 | 31 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $300,563 | 31 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SCREEN FAILURES | ACIST MEDICAL SYSTEMS, INC. | $54,015 | 0 |
| FFR | ACIST MEDICAL SYSTEMS, INC. | $51,336 | 0 |
| RXI FFR STUDY | ACIST MEDICAL SYSTEMS, INC. | $45,000 | 0 |
| UBDIT | ACIST MEDICAL SYSTEMS, INC. | $27,278 | 0 |
| SCREEN FAILURES - Q4 2016 | ACIST MEDICAL SYSTEMS, INC. | $23,500 | 0 |
| SUBJECTS: 110-004/005/006 | ACIST MEDICAL SYSTEMS, INC. | $20,000 | 0 |
| INTERVENTIONAL CARDIOLOGY FELLOWSHIP | ACIST MEDICAL SYSTEMS, INC. | $15,000 | 0 |
| SCREEN FAILURE SUBJECT/START UP FEE | ACIST MEDICAL SYSTEMS, INC. | $12,995 | 0 |
| EXHIBIT BOOTH | ACIST MEDICAL SYSTEMS, INC. | $11,500 | 0 |
| CONTRACT: CON000000058192 - 2/1/17 - 5/31/17 | ACIST MEDICAL SYSTEMS, INC. | $8,238 | 0 |
| ACIST-FFR CLINICAL TRIAL | ACIST MEDICAL SYSTEMS, INC. | $7,332 | 1 |
| DR. INDER SINGH SPEAKING ENGAGEMENTS | ACIST MEDICAL SYSTEMS, INC. | $4,000 | 1 |
| MEDICAL ADVISOR BOARD MEETING | ACIST MEDICAL SYSTEMS, INC. | $3,411 | 1 |
| PROGRAM CONTENT DEVELOPMENT | ACIST MEDICAL SYSTEMS, INC. | $3,000 | 1 |
| MONITORING FEE/SCREENING LOG | ACIST MEDICAL SYSTEMS, INC. | $2,600 | 0 |
| STUDY: #56119 ACIST-FFR | ACIST MEDICAL SYSTEMS, INC. | $2,250 | 0 |
| CONSULTATION TO ACIST | ACIST MEDICAL SYSTEMS, INC. | $1,833 | 1 |
| PROJECT: EUROPCR | ACIST MEDICAL SYSTEMS, INC. | $1,575 | 1 |
| ACIST BREAKFAST PROGRAM AT SCAI2017 | ACIST MEDICAL SYSTEMS, INC. | $1,500 | 1 |
| ACIST FFR CLINICAL STUDY | ACIST MEDICAL SYSTEMS, INC. | $1,500 | 0 |
Ad
Manufacturing Companies
- ACIST MEDICAL SYSTEMS, INC. $300,563
Product Information
- Type Drug
- Total Payments $300,563
- Total Doctors 3
- Transactions 31
About CVI INJECTORS
CVI INJECTORS is a drug associated with $300,563 in payments to 3 healthcare providers, recorded across 31 transactions in the CMS Open Payments database. The primary manufacturer is ACIST MEDICAL SYSTEMS, INC..
Payment data is available from 2017 to 2017. In 2017, $300,563 was paid across 31 transactions to 3 doctors.
The most common payment nature for CVI INJECTORS is "Unspecified" ($300,563, 100.0% of total).
CVI INJECTORS is associated with 20 research studies, including "SCREEN FAILURES" ($54,015).